MAPT and Alzheimer disease: In frontal, occipital, parietal, and temporal cortex, in addition to the amygdala, anterior hippocampus, anterior and posterior parahippocampus, and fusiform areas AD and MCI patients showed elevated levels of tau binding versus controls.